The University of Southampton
University of Southampton Institutional Repository

NAFLD severity and relationships with GDF-15 concentrations, PNPLA3-I148M genotype and adipose tissue biology.

NAFLD severity and relationships with GDF-15 concentrations, PNPLA3-I148M genotype and adipose tissue biology.
NAFLD severity and relationships with GDF-15 concentrations, PNPLA3-I148M genotype and adipose tissue biology.
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. The presence of clinically significant liver fibrosis (i.e. ≥F2 fibrosis) in NAFLD predicts all-cause and disease specific mortality. This reasonably early stage of liver fibrosis may be amenable to treatments that either regress or stabilise the fibrotic liver disease preventing further progression to advanced liver fibrosis, cirrhosis, and liver failure. Obesity and type 2 diabetes mellitus (T2DM) are known risk factors associated with an increased risk of liver fibrosis. Three candidate mediators/influencing factors that may be involved in the development of liver fibrosis in NAFLD are growth differentiation factor-15 (GDF-15) concentrations, PNPLA3-I148M genotype and altered adipose tissue (AT) biology. The aims of this thesis were to explore in patients with NAFLD, whether ≥F2 liver fibrosis associates with a) GDF-15, and whether GDF-15 concentrations influences the known association between T2DM and ≥F2 liver fibrosis; b) presence of the PNPLA3-I148M variant and measures of subcutaneous AT (SAT) lipid composition; and whether the PNPLA3-I148M variant associates with alterations in SAT lipid and transcriptomic profiles; and c) alterations in genetic signatures of SAT function. Concentrations of GDF-15 were independently associated with the presence of ≥F2 liver fibrosis and influenced the association between T2DM and ≥F2 liver fibrosis. HbA1c concentrations explained one-third of the variance in GDF-15 concentrations. The composition of lipids in SAT was not linked to liver fibrosis severity, however, the presence of the PNPLA3-I148M variant was associated with increased liver fat content and enrichment of polyunsaturated fatty acids (PUFAs) in SAT triglycerides but not with alterations in SAT transcriptomic profiles. The presence ≥F2 liver fibrosis was associated with an enrichment in the expression of genes associated with inflammation and extracellular matrix remodelling in SAT. Furthermore, a gene expression signature of collagen expression in SAT was able to distinguish between patients stratified by the presence vs absence of ≥F2 liver fibrosis. Collectively, these findings provide a novel understanding for the potential role of GDF-15 concentrations, the PNPLA3-I148M genotype and adipose tissue biology in liver fibrosis and liver fat, within the spectrum of liver disease encapsulated in patients with NAFLD.
University of Southampton
Bilson, Josh
a99f9320-335c-47c8-bf30-07df48a5467d
Bilson, Josh
a99f9320-335c-47c8-bf30-07df48a5467d
Sethi, Jaswinder
923f1a81-91e4-46cd-8853-bb4a979f5a85
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6

Bilson, Josh (2023) NAFLD severity and relationships with GDF-15 concentrations, PNPLA3-I148M genotype and adipose tissue biology. University of Southampton, Doctoral Thesis, 285pp.

Record type: Thesis (Doctoral)

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. The presence of clinically significant liver fibrosis (i.e. ≥F2 fibrosis) in NAFLD predicts all-cause and disease specific mortality. This reasonably early stage of liver fibrosis may be amenable to treatments that either regress or stabilise the fibrotic liver disease preventing further progression to advanced liver fibrosis, cirrhosis, and liver failure. Obesity and type 2 diabetes mellitus (T2DM) are known risk factors associated with an increased risk of liver fibrosis. Three candidate mediators/influencing factors that may be involved in the development of liver fibrosis in NAFLD are growth differentiation factor-15 (GDF-15) concentrations, PNPLA3-I148M genotype and altered adipose tissue (AT) biology. The aims of this thesis were to explore in patients with NAFLD, whether ≥F2 liver fibrosis associates with a) GDF-15, and whether GDF-15 concentrations influences the known association between T2DM and ≥F2 liver fibrosis; b) presence of the PNPLA3-I148M variant and measures of subcutaneous AT (SAT) lipid composition; and whether the PNPLA3-I148M variant associates with alterations in SAT lipid and transcriptomic profiles; and c) alterations in genetic signatures of SAT function. Concentrations of GDF-15 were independently associated with the presence of ≥F2 liver fibrosis and influenced the association between T2DM and ≥F2 liver fibrosis. HbA1c concentrations explained one-third of the variance in GDF-15 concentrations. The composition of lipids in SAT was not linked to liver fibrosis severity, however, the presence of the PNPLA3-I148M variant was associated with increased liver fat content and enrichment of polyunsaturated fatty acids (PUFAs) in SAT triglycerides but not with alterations in SAT transcriptomic profiles. The presence ≥F2 liver fibrosis was associated with an enrichment in the expression of genes associated with inflammation and extracellular matrix remodelling in SAT. Furthermore, a gene expression signature of collagen expression in SAT was able to distinguish between patients stratified by the presence vs absence of ≥F2 liver fibrosis. Collectively, these findings provide a novel understanding for the potential role of GDF-15 concentrations, the PNPLA3-I148M genotype and adipose tissue biology in liver fibrosis and liver fat, within the spectrum of liver disease encapsulated in patients with NAFLD.

Text
Josh_Bilson_PhD_Thesis_PDFA - Version of Record
Available under License University of Southampton Thesis Licence.
Download (6MB)
Text
Final-thesis-submission-Examination-Mr-Josh-Bilson
Restricted to Repository staff only

More information

Published date: June 2023

Identifiers

Local EPrints ID: 478342
URI: http://eprints.soton.ac.uk/id/eprint/478342
PURE UUID: 89f63ce6-4848-4bfa-a00b-9807f093c8e7
ORCID for Josh Bilson: ORCID iD orcid.org/0000-0003-4665-3886
ORCID for Jaswinder Sethi: ORCID iD orcid.org/0000-0003-4157-0475
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753
ORCID for Philip Calder: ORCID iD orcid.org/0000-0002-6038-710X

Catalogue record

Date deposited: 28 Jun 2023 16:58
Last modified: 13 Aug 2024 04:01

Export record

Contributors

Author: Josh Bilson ORCID iD
Thesis advisor: Jaswinder Sethi ORCID iD
Thesis advisor: Christopher Byrne ORCID iD
Thesis advisor: Philip Calder ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×